{{:images:drugs:drug_name_structure.png?220|Drug Name (chemical structure)}}
^ Drug Name |
| Brand Names | Brand1®, Brand2® |
| Drug Class | [[namespace:class:start|Class Name]] |
| Subclass | [[namespace:class:subclass|Subclass]] |
| Primary Indications | [[disease:page|Indication 1]]; [[disease:page|Indication 2]] |
| Route(s) | Oral / IV / SQ / INH |
| Onset | |
| Duration | |
| Metabolism | CYP ___ / none |
| Half-life | |
| Elimination | Renal / Hepatic / Both |
| Pregnancy | |
| Renal Adjustment | Yes / No |
| Hepatic Adjustment | Yes / No |
| Black Box Warning | Yes / No |
| Controlled | No / C-II / C-IV |
| FDA Approval | YYYY |
====== Generic (Brand®) ======
Common
First-line
===== Overview =====
One tight paragraph:
* What the drug is
* Where it fits clinically (first-line vs add-on)
* The “why it matters” outcome or key role
===== Mechanism of Action =====
* Primary target (receptor/enzyme/transporter):
* Downstream signal/pathway:
* Net physiologic effect (what variable changes):
* Why that helps the disease state:
===== Indications =====
* [[disease:page|Indication 1]]
* [[disease:page|Indication 2]]
* Common off-label:
* [[disease:page|Off-label 1]]
===== Black Box Warning =====
* (If none, delete this entire blackbox section.)
===== Contraindications =====
Absolute:
*
Relative / Cautions:
*
===== Dosing =====
Adult:
* Starting dose:
* Typical dose:
* Max dose:
Titration:
*
Renal dosing:
*
Hepatic dosing:
*
Special populations:
* Elderly:
* Pregnancy:
===== Pharmacokinetics =====
Absorption:
*
Bioavailability:
*
Protein binding:
*
Distribution:
*
Metabolism:
* [[cyp:start|CYP pathways]] (if relevant)
Half-life:
*
Elimination:
* Renal / Hepatic / Both
===== Adverse Effects =====
Common:
*
Serious:
*
Mechanism-based:
*
===== Drug Interactions =====
CYP:
* Inhibitors:
* Inducers:
Additive physiologic effects:
*
High-yield “do not miss”:
*
===== Monitoring =====
Vitals:
*
Labs:
*
ECG (if relevant):
*
Clinical response:
*
===== Clinical Pearls =====
*
*
*
===== Comparison Within Class =====
* How it differs from others in [[namespace:class:start|Class Name]]:
* potency / selectivity:
* duration:
* renal vs hepatic clearance:
* outcome evidence:
* “best use case” patient:
===== Related =====
* [[namespace:class:start|Class: Class Name]]
* [[module:start|Module Landing Page]]
* [[endocrine:start|Endocrine Pharmacology]] (or [[cardio:intro:start|Cardiovascular Pharmacology]])